wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33880064-2B724938-8C17-457B-B234-FD482641AFBE
Q33880064-2B724938-8C17-457B-B234-FD482641AFBE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33880064-2B724938-8C17-457B-B234-FD482641AFBE
Cabozantinib (XL184) Inhibits Growth and Invasion of Preclinical TNBC Models.
P2860
Q33880064-2B724938-8C17-457B-B234-FD482641AFBE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33880064-2B724938-8C17-457B-B234-FD482641AFBE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d33eeb88daf7ede4c8c0ff5766aea5f01275a89f
P2860
Cabozantinib in patients with advanced prostate cancer: results of a phase II randomized discontinuation trial.